ARCHIVES

In Phase II Study, NKTR-102 Shows Objective Response

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

DCBD Board Okays Concept Of Program Announcement To Stimulate Human Monoclonal Antibody Research

June 4, 1982

FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993

January 10, 1992

First Clinical Guidelines On Ductal Lavage Published

March 29, 2002

In Brief: Appropriations Hearings Scheduled; Zubro Heads AACI, Nelson Elected ACCC President

February 10, 1978

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

April 10, 1998